NOMIFENSINE - EFFECT IN PARKINSONIAN-PATIENTS NOT RECEIVING LEVODOPA

被引:21
作者
PARK, DM [1 ]
FINDLEY, LJ [1 ]
HANKS, G [1 ]
SANDLER, M [1 ]
机构
[1] CHARING CROSS HOSP,DEPT NEUROL,LONDON W6 8RF,ENGLAND
关键词
D O I
10.1136/jnnp.44.4.352
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:352 / 354
页数:3
相关论文
共 15 条
[1]   METHYLPHENIDATE-LIKE EFFECTS OF NEW ANTIDEPRESSANT DRUG NOMIFENSINE (HOE 984) [J].
BRAESTRUP, C ;
SCHEELKRUGER, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 38 (02) :305-312
[2]   NOMIFENSINE - POTENT DOPAMINERGIC AGONIST OF ANTIPARKINSON POTENTIAL [J].
COSTALL, B ;
KELLY, DM ;
NAYLOR, RJ .
PSYCHOPHARMACOLOGIA, 1975, 41 (02) :153-164
[3]  
HANKS GW, 1981, PROGR PARKINSONS DIS
[4]  
HORNYKIEWICZ O, 1973, ADV NEUROL, V2, P1
[5]   NOMIFENSINE - NEW POTENT INHIBITOR OF DOPAMINE UPTAKE INTO SYNAPTOSOMES FROM RAT-BRAIN CORPUS STRIATUM [J].
HUNT, P ;
KANNENGIESSER, MH ;
RAYNAUD, JP .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1974, 26 (05) :370-371
[6]  
MARSDEN CD, 1977, LANCET, V1, P345
[7]  
MINDHAM RHS, 1974, BRIT J HOSP MED, V11, P411
[8]  
MINDHAM RHS, 1976, PSYCHOL MED, V6, P25
[9]  
NICHOLSON PA, 1977, BRIT J CLIN PHARMACO, V4, pS53
[10]  
RINNE UK, 1978, ACTA NEUROL SCAND, V57, P77